Abstract:MicroRNAs (miRNAs) act as important gene regulators in human genomes and their aberrant expression links to many malignancies. We previously identified a different characteristic miRNA expression profile in cervical cancer from that in cervical normal tissues, including the downregulated miR-424. However, the role and mechanism of miR-424 in cervical cancer still remain unknown. Here, we focused on identifying the tumor-suppressive function and clinical significance of miR-424 and exploring the mechanistic relevance by characterizing its target. We showed a significantly decreased expression of miR-424 in 147 cervical cancer tissues versus 74 cervical normal tissues by performing quantitative RT–PCR. In 147 cervical cancer tissue samples, low-level expression of miR-424 was positively correlated with poor tumor differentiation, advanced clinical stage, lymph node metastasis and other poor prognostic clinicopathological parameters. Further in vitro observations showed that enforced expression of miR-424 inhibited cell growth by both enhancing apoptosis and blocking G1/S transition, and suppressed cell migration and invasion in two human cervical cancer cell lines, SiHa and CaSki, implying that miR-424 functions as a tumor suppressor in the progression of cervical cancer. Interestingly, overexpression of miR-424 inhibited the expression of protein checkpoint kinase 1 (Chk1) and phosphorylated Chk1 (p-Chk1) at residues Ser345 and decreased the activity of luciferase-reporter containing the 3′-untranslated region (UTR) of Chk1 with predicted miR-424-binding site. Moreover, miR-424 expression levels were inversely correlated with Chk1 and p-Chk1 protein levels in both cervical cancer and normal tissues. Furthermore, RNAi-mediated knockdown of Chk1 decreased matrix metalloproteinase 9 expression and phenocopied the tumor suppressive effects of miR-424 in cell models. Taken together, our results identify a crucial tumor suppressive role of miR-424 in the progression of cervical cancer at least partly via upreglating the expression of Chk1 and p-Chk1, and suggest that miR-424 might be a candidate of prognostic predictor or an anticancer therapeutic target for cervical cancer patients.

MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression

MiR-526b Suppresses Cell Proliferation, Cell Invasion and Epithelial-Mesenchymal Transition in Breast Cancer by Targeting Twist1

miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis

Mir-214-3p Inhibits Epithelial-to-mesenchymal Transition and Metastasis of Endometrial Cancer Cells by Targeting TWIST1

Expression of Survivin in Endometrial Cancer and Its Role in Regulating Apoptosis of Endometrial Cancer Cells

MicroRNA-34a Inhibits Cells Proliferation and Invasion by Downregulating Notch1 in Endometrial Cancer

Suppressive Effect of Microrna-449A on the NDRG1/PTEN/AKT Axis Regulates Endometrial Cancer Growth and Metastasis

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

Effects of CDKN2B-AS1 on cellular proliferation, invasion and AKT3 expression are attenuated by miR-424-5p in a model of ovarian endometriosis

microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.

MicroRNA-7 Inhibits Epithelial-to-mesenchymal Transition and Metastasis of Breast Cancer Cells Via Targeting FAK Expression.

MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation

miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition

MicroRNA-543 Acts As a Prognostic Marker and Promotes the Cell Proliferation in Cervical Cancer by BRCA1-interacting Protein 1.

MiR-542-3p, a Microrna Targeting CDK14, Suppresses Cell Proliferation, Invasiveness, and Tumorigenesis of Epithelial Ovarian Cancer

The role of miR-34c-5p/Notch in epithelial-mesenchymal transition (EMT) in endometriosis

MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Krüppel-like factor 6

MiR-195 Inhibits Proliferation and Growth and Induces Apoptosis of Endometrial Stromal Cells by Targeting FKN.

MicroRNA-342 Promotes the Malignant-Like Phenotype of Endometrial Stromal Cells Via Regulation of Annexin A2.

MicroRNA-219-5p Inhibits the Proliferation, Migration, and Invasion of Epithelial Ovarian Cancer Cells by Targeting the Twist/Wnt/β-catenin Signaling Pathway.

Mir-4324 Inhibits Ovarian Cancer Progression by Targeting FEN1